SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma informs about board meeting

30 Jan 2016 Evaluate

Natco Pharma has informed that a meeting of the Board of Directors of the Company will be held on February 11, 2016, to consider the unaudited financial Results for the quarter and nine months ended December 31, 2015 and related matters (Q3); and to consider Interim Dividend, if any, for the financial year 2015-16 and related matters etc. Further, the Trading Window for dealing in the securities of the Company will be closed for Promoters, Directors, Connected Persons, Insiders, Employees and their immediate relatives from February 03, 2016 to February 13, 2016. It will be opened from February 15, 2016.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1174.00 19.80 (1.72%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×